Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.770
+0.590 (14.11%)
Oct 23, 2025, 4:00 PM EDT - Market closed

Company Description

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.

The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.

The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025.

Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Turn Therapeutics Inc.
CountryUnited States
Founded2015
IndustryBiotechnology
SectorHealthcare
Employees4
CEOBradley Burnam

Contact Details

Address:
250 N Westlake Blvd
Westlake Village, California 91362
United States
Phone818 546 4011
Websiteturntherapeutics.com

Stock Details

Ticker SymbolTTRX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0002023016
Employer ID32-0456090
SIC Code2834

Key Executives

NamePosition
Bradley BurnamChief Executive Officer
Zuraiz ChaudharyChief Financial Officer

Latest SEC Filings

DateTypeTitle
Oct 22, 20258-KCurrent Report
Oct 9, 2025S-1General form for registration of securities under the Securities Act of 1933
Oct 8, 2025424B4Prospectus
Oct 7, 2025S-8Securities to be offered to employees in employee benefit plans
Oct 7, 2025CERTCertification by an exchange approving securities for listing
Oct 7, 20258-A12B/AFiling
Oct 2, 20258-KCurrent Report
Sep 30, 2025EFFECTNotice of Effectiveness
Sep 29, 20258-A12BRegistration of securities
Sep 24, 2025S-1/A[Amend] General form for registration of securities under the Securities Act of 1933